OBJECTIVE: To determine the rate of diagnostic conversion from an operationalized diagnosis of bipolar disorder not otherwise specified (BP-NOS) to bipolar I disorder (BP-I) or bipolar II disorder (BP-II) in youth over prospective follow-up and to identify factors associated with conversion. METHOD: Subjects were 140 children and adolescents recruited from clinical referrals or advertisement who met operationalized criteria for BP-NOS at intake and participated in at least one follow-up evaluation (91% of initial cohort). Diagnoses were assessed at follow-up interviews using the Longitudinal Interval Follow-Up Evaluation. The mean duration of follow-up was 5 years and the mean interval between assessments was 8.2 months. RESULTS: Diagnostic conversion to BP-I or BP-II occurred in 63 subjects (45%): 32 (23%) to BP-I (nine of whom had initially converted to BP-II) and 31 to only BP-II (22%). Median time from intake to conversion was 58 weeks. First- or second-degree family history of mania or hypomania was the strongest baseline predictor of diagnostic conversion (p = .006). Over follow-up, conversion was associated with greater intensity of hypomanic symptoms and with greater exposure to specialized, intensive outpatient psychosocial treatments. There was no association between conversion and exposure to treatment with particular medication classes. CONCLUSIONS: Children and adolescents referred with mood symptoms that meet operationalized criteria for BP-NOS, particularly those with a family history of BP, frequently progress to BP-I or BP-II. Efforts to identify these youth and effectively intervene may have the potential to curtail the progression of mood disorders in this high-risk population.
OBJECTIVE: To determine the rate of diagnostic conversion from an operationalized diagnosis of bipolar disorder not otherwise specified (BP-NOS) to bipolar I disorder (BP-I) or bipolar II disorder (BP-II) in youth over prospective follow-up and to identify factors associated with conversion. METHOD: Subjects were 140 children and adolescents recruited from clinical referrals or advertisement who met operationalized criteria for BP-NOS at intake and participated in at least one follow-up evaluation (91% of initial cohort). Diagnoses were assessed at follow-up interviews using the Longitudinal Interval Follow-Up Evaluation. The mean duration of follow-up was 5 years and the mean interval between assessments was 8.2 months. RESULTS: Diagnostic conversion to BP-I or BP-II occurred in 63 subjects (45%): 32 (23%) to BP-I (nine of whom had initially converted to BP-II) and 31 to only BP-II (22%). Median time from intake to conversion was 58 weeks. First- or second-degree family history of mania or hypomania was the strongest baseline predictor of diagnostic conversion (p = .006). Over follow-up, conversion was associated with greater intensity of hypomanic symptoms and with greater exposure to specialized, intensive outpatientpsychosocial treatments. There was no association between conversion and exposure to treatment with particular medication classes. CONCLUSIONS:Children and adolescents referred with mood symptoms that meet operationalized criteria for BP-NOS, particularly those with a family history of BP, frequently progress to BP-I or BP-II. Efforts to identify these youth and effectively intervene may have the potential to curtail the progression of mood disorders in this high-risk population.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: G B Cassano; L Dell'Osso; E Frank; M Miniati; A Fagiolini; K Shear; S Pini; J Maser Journal: J Affect Disord Date: 1999-08 Impact factor: 4.839
Authors: Giovanni B Cassano; Paola Rucci; Ellen Frank; Andrea Fagiolini; Liliana Dell'Osso; M Katherine Shear; David J Kupfer Journal: Am J Psychiatry Date: 2004-07 Impact factor: 18.112
Authors: David J Miklowitz; Christopher D Schneck; Patricia D Walshaw; Amy S Garrett; Manpreet K Singh; Catherine A Sugar; Kiki D Chang Journal: Early Interv Psychiatry Date: 2017-08-04 Impact factor: 2.732
Authors: Manpreet K Singh; Booil Jo; Nancy E Adleman; Meghan Howe; Layla Bararpour; Ryan G Kelley; Daniel Spielman; Kiki D Chang Journal: Psychiatry Res Date: 2013-09-09 Impact factor: 3.222
Authors: Rebecca S Siegel; Bettina Hoeppner; Shirley Yen; Robert L Stout; Lauren M Weinstock; Heather M Hower; Boris Birmaher; Tina R Goldstein; Benjamin I Goldstein; Jeffrey I Hunt; Michael Strober; David A Axelson; Mary Kay Gill; Martin B Keller Journal: J Nerv Ment Dis Date: 2015-03 Impact factor: 2.254
Authors: Heather A MacPherson; Amanda L Ruggieri; Rachel E Christensen; Elana Schettini; Kerri L Kim; Sarah A Thomas; Daniel P Dickstein Journal: J Affect Disord Date: 2018-04-16 Impact factor: 4.839
Authors: Boris Birmaher; John A Merranko; Tina R Goldstein; Mary Kay Gill; Benjamin I Goldstein; Heather Hower; Shirley Yen; Danella Hafeman; Michael Strober; Rasim S Diler; David Axelson; Neal D Ryan; Martin B Keller Journal: J Am Acad Child Adolesc Psychiatry Date: 2018-08-07 Impact factor: 8.829
Authors: D G Kondo; T L Hellem; X-F Shi; Y H Sung; A P Prescot; T S Kim; R S Huber; L N Forrest; P F Renshaw Journal: AJNR Am J Neuroradiol Date: 2014-02-20 Impact factor: 3.825
Authors: Carrie A H Vaudreuil; Stephen V Faraone; Maura Di Salvo; Janet R Wozniak; Rebecca A Wolenski; Nicholas W Carrellas; Joseph Biederman Journal: Bipolar Disord Date: 2018-12-19 Impact factor: 6.744
Authors: Marc J Weintraub; Christopher D Schneck; Patricia D Walshaw; Kiki D Chang; Aimee E Sullivan; Manpreet K Singh; David J Miklowitz Journal: J Affect Disord Date: 2020-08-13 Impact factor: 4.839
Authors: José M Martínez-Ortega; Benjamin I Goldstein; Luis Gutiérrez-Rojas; Regina Sala; Shuai Wang; Carlos Blanco Journal: J Psychiatr Res Date: 2013-04-11 Impact factor: 4.791
Authors: Maria Andreu Pascual; Jessica C Levenson; John Merranko; Mary Kay Gill; Heather Hower; Shirley Yen; Michael Strober; Tina R Goldstein; Benjamin I Goldstein; Neal D Ryan; Lauren M Weinstock; Martin B Keller; David Axelson; Boris Birmaher Journal: J Affect Disord Date: 2020-05-22 Impact factor: 4.839